The COVID-19 pandemic has shaken the world and the rapid delivery of vaccines against the virus has raised many questions. Doubts have been raised about the effectiveness and safety of the vaccine in pregnant and breastfeeding women, hence the need to assess vaccination coverage of postpartum women at the Gaspard Kamara health center. We therefore carried out a cross-sectional analytical study from May 31 to June 28, 2022 on all women who gave birth at the Gaspard Kamara health center. Exhaustive recruitment was carried out and the data were analyzed using the SSP software version 2022. In total, 235 women participated in the study, with a mean age of 28.22 ± 5.96 years and extremes 16 and 44 years old. More than half of the patients (68.94%) had given birth vaginally. Those with secondary education accounted for 72.34%. Less than a quarter of women (7.23%) tested positive for COVID19 and 96.60% of them received information on the fight against COVID19, with the media being their main source of information. Less than half (40.43%) knew the vaccines available in Senegal, Johnson & Johnson being the best known. The majority of women (82.55%) believe in the effectiveness of vaccination to eradicate the disease. Age (30 years), lack of information on the fight against COVID19, lack of knowledge of the risks of serious forms in FE, knowledge of the availability of the vaccine in Senegal and vaccination of the spouse were statistically associated with vaccination against COVID19 among women in this country. study. Conclusion: The results of this study show the need to strengthen awareness and communication on the effectiveness and safety of vaccines among pregnant women, particularly those under 30 years of age. Let women know that they can be vaccinated at any age and during any trimester of pregnancy and breastfeeding.
| Published in | Central African Journal of Public Health (Volume 10, Issue 6) |
| DOI | 10.11648/j.cajph.20241006.12 |
| Page(s) | 233-241 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2024. Published by Science Publishing Group |
Prevention, COVID-19, Vaccination, Senegal
| [1] | Liu M, Chen X. COVID-19 basics and vaccine development from a Canadian perspective. Can J Microbiol. February 1, 2021; 67(2): 112-8. |
| [2] | Peng XL, Cheng JSY, Gong HL, Yuan MD, Zhao XH, Li Z et al. Advances in SARS-CoV-2 vaccine design and development. Mil Med Res. December 16, 2021; 8: 67. |
| [3] | Manning ML, Gerolamo AM, Marino MA, Hanson-Zalot ME, Pogorzelska-Maziarz M. COVID-19 vaccination preparedness among nursing faculty and nursing students. Perspectives from nurses. July 1, 2021; 69(4): 565-73. |
| [4] |
Mostaghimi D, Valdez CN, Larson HT, Kalinich CC, Iwasaki A. Prevention of host-to-host transmission by SARS-CoV-2 vaccines. Lancet Infect Dis [Internet]. September 14, 2021 [cited November 6, 2021]; 0(0). Available at:
https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00472-2/fulltext |
| [5] | Alphonse Yapi-Diahou (Dir.). “Everyday COVID-19” notebook. 125 p., 2020. ffhal-02859844 |
| [6] | Note 3 CORAF COVID vaccine and other vaccines Senegal 230221.pdf [Internet]. [cited July 28, 2022]. Available at: |
| [7] | Razzaghi H, Yankey D, Vashist K, Lu June P, Kriss JL, Nguyen KH et al. COVID-19 vaccination coverage and intention among women aged 18-49 by pregnancy status, United States, April-November 2021. Vaccine. July 30, 2022; 40(32): 4554-63. |
| [8] | Sutton D, D'Alton M, Zhang Y, Kahe K, Cepin A, Goffman D et al. Acceptance of COVID-19 vaccine among pregnant, lactating, and non-pregnant women of childbearing age. Am J Obstet Gynecol MFM. September 1, 2021; 3(5): 100403. |
| [9] | WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2021.1-eng.pdf [Internet]. [cited July 27, 2022]. Available at: |
| [10] | Within communities in Senegal.pdf [Internet]. [cited August 1, 2022]. Available at: |
| [11] |
Bulletin N°42 June 2021.pdf [Internet]. [cited July 27, 2022]. Available at:
https://www.sante.gouv.sn/sites/default/files/Bulletin%20N%C2%B042%20Juin%202021.pdf |
| [12] |
Li M, Luo Y, Watson R, Zheng Y, Ren J, Tang J et al. Healthcare worker (HCW) attitudes and associated factors toward COVID-19 vaccination: a rapid systematic review. Postgrad Med J [Internet]. June 30, 2021 [cited August 17, 2022]; Available at:
https://pmj.bmj.com/content/early/2021/06/29/postgradmedj-2021-140195 |
| [13] | WHO. Conducting community engagement for COVID-19 vaccines: Interim guidance 31 January 2021. |
| [14] |
News P. Illiteracy in Senegal: truncated figures [Internet]. Pulse Senegal. Apr 200 [cited Aug 19, 2022]. Available at:
https://www.pulse.sn/news/analphabetisme-au-senegal-des-chiffres-tronques/y39cxbd |
| [15] | Understanding barriers to COVID-19 vaccination in sub-Saharan Africa [Internet]. [cited August 1, 2022]. Available at: |
| [16] | ev i dence_brief_sur_lacceptabilite_du_vaccin_dans_la_communaute.pdf [Internet]. [cited August 8, 2022]. Available at: |
| [17] |
senegal_fr_112221_Final.pdf [Internet]. [cited May 17, 2022]. Available at:
https://preventepidemics.org/wp-content/uploads/2021/11/senegal_fr_112221_Final.pdf |
| [18] | Haifa Khemiri ab, Iolanda Mangone c, Mariem Gdoura ab, Khawla Mefteh. Dynamics of circulation of SARS-CoV-2 variants in the Tunisian pediatric population, during successive waves, from March 2020 to September 2022. Volume 344, June 2024, 199353. |
| [19] | Sow K, Desclaux A, Billaud A. Fears and rumors linked to COVID-19: 25. |
| [20] | Allotey J, Fernandez S, Bonet M, Stallings E, Yap M, Kew T et al. Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 during pregnancy: a living systematic review and meta-analysis. BMJ. September 1, 2020; m3320. |
| [21] | Mohamed Mhereeg, Hope Jones, Jonathan Kennedy, Mike Seaborne, Michael Parker. COVID-19 vaccination in pregnancy: views and vaccination uptake rates in pregnancy, a mixed methods analysis from SAIL and the Born-In-Wales Birth Cohort. Mhereeg et al. BMC Infectious Diseases (2022) 22: 932. |
APA Style
Leye, M. M. M., Touré, A. O., Mendy, B. (2024). Evaluation of Vaccination Coverage Against COVID-19 Among Postpartum Women at the Gaspard Kamara Health Center in Senegal in 2020. Central African Journal of Public Health, 10(6), 233-241. https://doi.org/10.11648/j.cajph.20241006.12
ACS Style
Leye, M. M. M.; Touré, A. O.; Mendy, B. Evaluation of Vaccination Coverage Against COVID-19 Among Postpartum Women at the Gaspard Kamara Health Center in Senegal in 2020. Cent. Afr. J. Public Health 2024, 10(6), 233-241. doi: 10.11648/j.cajph.20241006.12
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.cajph.20241006.12,
author = {Mamadou Makhtar Mbacké Leye and Amadou Oury Touré and Brigitte Mendy},
title = {Evaluation of Vaccination Coverage Against COVID-19 Among Postpartum Women at the Gaspard Kamara Health Center in Senegal in 2020
},
journal = {Central African Journal of Public Health},
volume = {10},
number = {6},
pages = {233-241},
doi = {10.11648/j.cajph.20241006.12},
url = {https://doi.org/10.11648/j.cajph.20241006.12},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cajph.20241006.12},
abstract = {The COVID-19 pandemic has shaken the world and the rapid delivery of vaccines against the virus has raised many questions. Doubts have been raised about the effectiveness and safety of the vaccine in pregnant and breastfeeding women, hence the need to assess vaccination coverage of postpartum women at the Gaspard Kamara health center. We therefore carried out a cross-sectional analytical study from May 31 to June 28, 2022 on all women who gave birth at the Gaspard Kamara health center. Exhaustive recruitment was carried out and the data were analyzed using the SSP software version 2022. In total, 235 women participated in the study, with a mean age of 28.22 ± 5.96 years and extremes 16 and 44 years old. More than half of the patients (68.94%) had given birth vaginally. Those with secondary education accounted for 72.34%. Less than a quarter of women (7.23%) tested positive for COVID19 and 96.60% of them received information on the fight against COVID19, with the media being their main source of information. Less than half (40.43%) knew the vaccines available in Senegal, Johnson & Johnson being the best known. The majority of women (82.55%) believe in the effectiveness of vaccination to eradicate the disease. Age (30 years), lack of information on the fight against COVID19, lack of knowledge of the risks of serious forms in FE, knowledge of the availability of the vaccine in Senegal and vaccination of the spouse were statistically associated with vaccination against COVID19 among women in this country. study. Conclusion: The results of this study show the need to strengthen awareness and communication on the effectiveness and safety of vaccines among pregnant women, particularly those under 30 years of age. Let women know that they can be vaccinated at any age and during any trimester of pregnancy and breastfeeding.
},
year = {2024}
}
TY - JOUR T1 - Evaluation of Vaccination Coverage Against COVID-19 Among Postpartum Women at the Gaspard Kamara Health Center in Senegal in 2020 AU - Mamadou Makhtar Mbacké Leye AU - Amadou Oury Touré AU - Brigitte Mendy Y1 - 2024/11/18 PY - 2024 N1 - https://doi.org/10.11648/j.cajph.20241006.12 DO - 10.11648/j.cajph.20241006.12 T2 - Central African Journal of Public Health JF - Central African Journal of Public Health JO - Central African Journal of Public Health SP - 233 EP - 241 PB - Science Publishing Group SN - 2575-5781 UR - https://doi.org/10.11648/j.cajph.20241006.12 AB - The COVID-19 pandemic has shaken the world and the rapid delivery of vaccines against the virus has raised many questions. Doubts have been raised about the effectiveness and safety of the vaccine in pregnant and breastfeeding women, hence the need to assess vaccination coverage of postpartum women at the Gaspard Kamara health center. We therefore carried out a cross-sectional analytical study from May 31 to June 28, 2022 on all women who gave birth at the Gaspard Kamara health center. Exhaustive recruitment was carried out and the data were analyzed using the SSP software version 2022. In total, 235 women participated in the study, with a mean age of 28.22 ± 5.96 years and extremes 16 and 44 years old. More than half of the patients (68.94%) had given birth vaginally. Those with secondary education accounted for 72.34%. Less than a quarter of women (7.23%) tested positive for COVID19 and 96.60% of them received information on the fight against COVID19, with the media being their main source of information. Less than half (40.43%) knew the vaccines available in Senegal, Johnson & Johnson being the best known. The majority of women (82.55%) believe in the effectiveness of vaccination to eradicate the disease. Age (30 years), lack of information on the fight against COVID19, lack of knowledge of the risks of serious forms in FE, knowledge of the availability of the vaccine in Senegal and vaccination of the spouse were statistically associated with vaccination against COVID19 among women in this country. study. Conclusion: The results of this study show the need to strengthen awareness and communication on the effectiveness and safety of vaccines among pregnant women, particularly those under 30 years of age. Let women know that they can be vaccinated at any age and during any trimester of pregnancy and breastfeeding. VL - 10 IS - 6 ER -
Chair of Public Health, Gamal Abdel Nasser University of Conakry, Conakry, Guinea
